Heparin and Low-Molecular-Weight Heparin
- 1 November 1998
- Vol. 114 (5), 489S-510S
- https://doi.org/10.1378/chest.114.5_supplement.489s
Abstract
No abstract availableKeywords
This publication has 202 references indexed in Scilit:
- Relation between systemic anticoagulation as determined by activated partial thromboplastin time and heparin measurements and in-hospital clinical events in unstable angina and non-Q wave myocardial infarctionAmerican Heart Journal, 1996
- Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapyThe American Journal of Cardiology, 1996
- The relationship of anticoagulation level and complications after successful percutaneous transluminal coronary angioplastyAmerican Heart Journal, 1992
- Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplastyAmerican Heart Journal, 1989
- The Antithrombotic Activity and Pharmacokinetics of Enoxaparine, A Low Molecular Weight Heparin, In Humans Given Single Subcutaneous Doses of 20 to 80 mgThe Journal of Clinical Pharmacology, 1988
- Activation of heparin cofactor II by heparin oligosaccharidesBiochemical and Biophysical Research Communications, 1988
- Role of heparin after intravenous thrombolytic therapy for acute myocardial infarctionThe American Journal of Cardiology, 1987
- Cutaneous reactions secondary to heparin injectionsJournal of the American Academy of Dermatology, 1985
- Structure-activity relationship in heparin: A synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activityBiochemical and Biophysical Research Communications, 1983
- Anticoagulant activity of heparin: Separation of high‐activity and low‐activity heparin species by affinity chromatography on immobilized antithrombinFEBS Letters, 1976